-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Spyre Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2020 to 2023.
- Spyre Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was 1.06 USD/shares, a 23.3% increase year-over-year.
- Spyre Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -20 USD/shares, a 219% decline year-over-year.
- Spyre Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was 13.8 USD/shares.
- Spyre Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -24.9 USD/shares, a 0.64% increase from 2021.
- Spyre Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was -25 USD/shares, a 1546% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)